adplus-dvertising
Connect with us

Health

Treating critically ill coronavirus patients with steroids reduces risk of death: study – Global News

Published

 on


Treating critically ill COVID-19 patients with corticosteroid drugs reduces the risk of death by 20 per cent, an analysis of seven international trials found on Wednesday, prompting the World Health Organisation to update its advice on treatment.

The analysis – which pooled data from separate trials of low dose hydrocortisone, dexamethasone and methylprednisolone – found that steroids improve survival rates of COVID-19 patients sick enough to be in intensive care in hospital.

Read more:
Companies testing next best thing to a coronavirus vaccine: an antibody drug

300x250x1

“This is equivalent to around 68 per cent of (the sickest COVID-19) patients surviving after treatment with corticosteroids, compared to around 60% surviving in the absence of corticosteroids,” the researchers said in a statement.

“Steroids are a cheap and readily available medication, and our analysis has confirmed that they are effective in reducing deaths amongst the people most severely affected by COVID-19,” Jonathan Sterne, a professor of medical statistics and epidemiology at Britain’s Bristol University who worked on the analysis, told the briefing.

Story continues below advertisement

He said the trials – conducted by researchers in Britain, Brazil, Canada, China, France, Spain, and the United States – gave a consistent message throughout, showing the drugs were beneficial in the sickest patients regardless of age or sex or how long patients had been ill.






3:08
Coronavirus: Early study hails steroid as ‘breakthrough’ COVID-19 drug


Coronavirus: Early study hails steroid as ‘breakthrough’ COVID-19 drug

The findings, published in the Journal of the American Medical Association, reinforce results that were hailed as a major breakthrough and announced in June, when dexamethasone became the first drug shown to be able to reduce death rates among severely sick COVID-19 patients.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Dexamethasone has been in widespread use in intensive care wards treating COVID-19 patients in some countries since then.

Martin Landray, a professor of medicine and epidemiology at the University of Oxford who worked on the dexamethasone trial that was a key part of the pooled analysis published on Wednesday, said the results mean doctors in hospitals across the world can safely switch to using the drugs to save lives.

Story continues below advertisement

Clear benefits

“These results are clear, and instantly usable in clinical practice,” he told reporters. “Among critically ill patients with COVID-19, low-dose corticosteroids…significantly reduce the risk of death.”

Researchers said the benefit was shown regardless of whether patients were on ventilation at the time they started treatment. They said the WHO would update its guidelines immediately to reflect the fresh results.

Read more:
This is what can happen to your lungs when you have coronavirus

Until the June findings on dexamethasone, no effective treatment had been shown to reduce death rates in patients with COVID-19, the respiratory disease caused by the new coronavirus.

More than 25 million people have been infected with COVID-19 and 856,876​ have died, according to a Reuters tally.

Gilead Sciences Inc’s remdesivir was authorized by United States regulators in May for use in patients with severe COVID-19 after trial data showed the antiviral drug helped shorten hospital recovery time.






1:45
Steroid shows promise in treating COVID-19


Steroid shows promise in treating COVID-19

Anthony Gordon, an Imperial College London professor who also worked on the analysis, said its results were good news for patients who become critically ill with COVID-19, but would not be enough to end outbreaks or ease infection control measures.

Story continues below advertisement

“Impressive as these results are, this is not a cure. We now have something that will help, but it is not a cure, so it’s vital that we keep up all the prevention strategies.”

© 2020 Reuters

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Health

Interior Health delivers nearly 800K immunization doses in 2023

Published

 on

Interior Health says it delivered nearly 800,000 immunization doses last year — a number almost equal to the region’s population.

The released figure of 784,980 comes during National Immunization Awareness Week, which runs April 22-30.

The health care organization, which serves a large area of around 820,000,  says it’s using the occasion to boost vaccine rates even though there may be post-pandemic vaccine fatigue.

300x250x1

“This is a very important initiative because it ensures that communicable diseases stay away from a region,” said Dr. Silvina Mema of Interior Health.

However, not all those doses were for COVID; the tally includes childhood immunizations plus immunizations for adults.

But IHA said immunizations are down from the height of the pandemic, when COVID vaccines were rolled out, though it seems to be on par with previous pre-pandemic years.

Interior Health says it’d like to see the overall immunization rate rise.

“Certainly there are some folks who have decided a vaccine is not for them. And they have their reasons,” said Jonathan Spence, manager of communicable disease prevention and control at Interior Health.

“I think there’s a lot of people who are hesitant, but that’s just simply because they have questions.

“And that’s actually part of what we’re celebrating this week is those public health nurses, those pharmacists, who can answer questions and answer questions with really good information around immunization.”

Mima echoed that sentiment.

“We take immunization very seriously. It’s a science-based program that has saved countless lives across the world and eliminated diseases that were before a threat and now we don’t see them anymore,” she said.

“So immunization is very important.”

 

728x90x4

Source link

Continue Reading

Health

Remnants of bird flu virus found in pasteurized milk, FDA says

Published

 on

The U.S. Food and Drug Administration said Tuesday that samples of pasteurized milk had tested positive for remnants of the bird flu virus that has infected dairy cows.

The agency stressed that the material is inactivated and that the findings “do not represent actual virus that may be a risk to consumers.” Officials added that they’re continuing to study the issue.

“To date, we have seen nothing that would change our assessment that the commercial milk supply is safe,” the FDA said in a statement.

The announcement comes nearly a month after an avian influenza virus that has sickened millions of wild and commercial birds in recent years was detected in dairy cows in at least eight states. The Agriculture Department says 33 herds have been affected to date.

300x250x1

FDA officials didn’t indicate how many samples they tested or where they were obtained. The agency has been evaluating milk during processing and from grocery stores, officials said. Results of additional tests are expected in “the next few days to weeks.”

The PCR lab test the FDA used would have detected viral genetic material even after live virus was killed by pasteurization, or heat treatment, said Lee-Ann Jaykus, an emeritus food microbiologist and virologist at North Carolina State University

“There is no evidence to date that this is infectious virus and the FDA is following up on that,” Jaykus said.

Officials with the FDA and the USDA had previously said milk from affected cattle did not enter the commercial supply. Milk from sick animals is supposed to be diverted and destroyed. Federal regulations require milk that enters interstate commerce to be pasteurized.

Because the detection of the bird flu virus known as Type A H5N1 in dairy cattle is new and the situation is evolving, no studies on the effects of pasteurization on the virus have been completed, FDA officials said. But past research shows that pasteurization is “very likely” to inactivate heat-sensitive viruses like H5N1, the agency added.

Matt Herrick, a spokesman for the International Dairy Foods Association, said that time and temperature regulations for pasteurization ensure that the commercial U.S. milk supply is safe. Remnants of the virus “have zero impact on human health,” he wrote in an email.

Scientists confirmed the H5N1 virus in dairy cows in March after weeks of reports that cows in Texas were suffering from a mysterious malady. The cows were lethargic and saw a dramatic reduction in milk production. Although the H5N1 virus is lethal to commercial poultry, most infected cattle seem to recover within two weeks, experts said.

To date, two people in U.S. have been infected with bird flu. A Texas dairy worker who was in close contact with an infected cow recently developed a mild eye infection and has recovered. In 2022, a prison inmate in a work program caught it while killing infected birds at a Colorado poultry farm. His only symptom was fatigue, and he recovered.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

 

728x90x4

Source link

Continue Reading

Health

Canada Falling Short in Adult Vaccination Rates – VOCM

Published

 on


Canada is about where it should be when it comes to childhood vaccines, but for adult vaccinations it’s a different story.

Dr. Vivien Brown of Immunize Canada says the overall population should have rates of between 80 and 90 per cent for most vaccines, but that is not the case.

She says most children are in that range but not for adult vaccines and ultimately the most at-risk populations are not being reached.

300x250x1

She says the population is under immunized for conditions such as pneumonia, shingles, tetanus, and pertussis.

Brown wants people to talk with their family physician or pharmacist to see if they are up-to-date on vaccines, and to get caught up because many are “killer diseases.”

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Trending